Download PDF
Clin Colon Rectal Surg 2015; 28(04): 205-214
DOI: 10.1055/s-0035-1564432
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Diagnostic Approach to Hereditary Colorectal Cancer Syndromes

Matthew F. Kalady
1   Department of Colorectal Surgery, Digestive Disease Institute, Cleveland, Ohio
2   Sanford R. Weiss, MD, Center for Hereditary Colorectal Neoplasia, Cleveland, Ohio
,
Brandie Heald
2   Sanford R. Weiss, MD, Center for Hereditary Colorectal Neoplasia, Cleveland, Ohio
3   Genomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio
› Author Affiliations
Further Information

Publication History

Publication Date:
20 November 2015 (online)

Also available at
    Permissions and Reprints

Abstract

Approximately 5 to 10% of colorectal cancers develop within a known hereditary syndrome. Specific underlying genetic mutations drive the clinical phenotype and it is imperative to determine the genetic etiology to provide meaningful surveillance and intervention. Recognizing potential patients and families with a hereditary predisposition is the first step in management. Syndromes can be categorized according to polyp burden as polyposis or nonpolyposis. Clinical assessment should start with a personal and family medical history, physical examination, and evaluation for the presence and type of colorectal polyps or cancers. Key information is gained from these simple steps and should guide the specific genetic analysis for diagnosis. Genetic counseling is a critical component to any hereditary colorectal cancer program and should be conducted before genetic testing to provide education about the implications of test results. This review focuses on the thought process that drives initial clinical evaluation and guides genetic testing for patients with suspected hereditary colorectal cancer syndromes.

Keywords

hereditary colorectal cancer syndromes - familial adenomatous polyposis - genetic testing - Lynch syndrome - hereditary nonpolyposis colorectal cancer - MYH-associated polyposis
 

  • References

  • 1 Jass JR. Hereditary non-polyposis colorectal cancer: the rise and fall of a confusing term. World J Gastroenterol 2006; 12 (31) 4943-4950
    CrossrefPubMedSearch in Google Scholar
  • 2 Giardiello FM, Allen JI, Axilbund JE , et al; US Multi-Society Task Force on Colorectal Cancer. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer. Gastroenterology 2014; 147 (2) 502-526
    CrossrefPubMedSearch in Google Scholar
  • 3 Hampel H, Frankel WL, Martin E , et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 2005; 352 (18) 1851-1860
    CrossrefPubMedSearch in Google Scholar
  • 4 Lindor NM, Rabe K, Petersen GM , et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 2005; 293 (16) 1979-1985
    CrossrefPubMedSearch in Google Scholar
  • 5 Jarrar AM, Milas M, Mitchell J , et al. Screening for thyroid cancer in patients with familial adenomatous polyposis. Ann Surg 2011; 253 (3) 515-521
    CrossrefPubMedSearch in Google Scholar
  • 6 Church J, Heald B, Burke C, Kalady M. Understanding MYH-associated neoplasia. Dis Colon Rectum 2012; 55 (3) 359-362
    CrossrefPubMedSearch in Google Scholar
  • 7 Kalady MF, Kravochuck SE, Heald B, Burke CA, Church JM. Defining the adenoma burden in Lynch syndrome. Dis Colon Rectum 2015; 58 (4) 388-392
    CrossrefPubMedSearch in Google Scholar
  • 8 Heald B, Mester J, Rybicki L, Orloff MS, Burke CA, Eng C. Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers. Gastroenterology 2010; 139 (6) 1927-1933
    CrossrefPubMedSearch in Google Scholar
  • 9 Boparai KS, Dekker E, Van Eeden S , et al. Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis. Gastroenterology 2008; 135 (6) 2014-2018
    CrossrefPubMedSearch in Google Scholar
  • 10 Castells A. MYH-associated polyposis: adenomas and hyperplastic polyps, partners in crime?. Gastroenterology 2008; 135 (6) 1857-1859
    CrossrefPubMedSearch in Google Scholar
  • 11 Jarrar AM, Church JM, Fay S, Kalady MF. Is the phenotype mixed or mistaken? Hereditary nonpolyposis colorectal cancer and hyperplastic polyposis syndrome. Dis Colon Rectum 2009; 52 (12) 1949-1955
    CrossrefPubMedSearch in Google Scholar
  • 12 Kalady MF, Jarrar A, Leach B , et al. Defining phenotypes and cancer risk in hyperplastic polyposis syndrome. Dis Colon Rectum 2011; 54 (2) 164-170
    CrossrefPubMedSearch in Google Scholar
  • 13 Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med 2009; 11 (1) 35-41
    CrossrefPubMedSearch in Google Scholar
  • 14 Genetic/Familial High-Risk Assessment. Colorectal. NCCN Clinical Practice Guidelines in Oncology; 2014
    Search in Google Scholar
  • 15 Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999; 116 (6) 1453-1456
    CrossrefPubMedSearch in Google Scholar
  • 16 Umar A, Boland CR, Terdiman JP , et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004; 96 (4) 261-268
    CrossrefPubMedSearch in Google Scholar
  • 17 Weissman SM, Burt R, Church J , et al. Identification of individuals at risk for Lynch syndrome using targeted evaluations and genetic testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer joint practice guideline. J Genet Couns 2012; 21 (4) 484-493
    CrossrefPubMedSearch in Google Scholar
  • 18 Heald B, Plesec T, Liu X , et al. Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing Lynch syndrome in a large academic medical center. J Clin Oncol 2013; 31 (10) 1336-1340
    CrossrefPubMedSearch in Google Scholar
  • 19 Kalady MF, Heald B, Pai R , et al. Utility of universal colorectal cancer screening for Lynch syndrome in advanced age. Presented at the 18th Annual Meeting of the Collaborative Group of the Americas, New Orleans, LA; Sep 15–16, 2014
    PubMed
  • 20 Aaltonen LA, Peltomäki P, Leach FS , et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993; 260 (5109) 812-816
    CrossrefPubMedSearch in Google Scholar
  • 21 Kim H, Jen J, Vogelstein B, Hamilton SR. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 1994; 145 (1) 148-156
    PubMedSearch in Google Scholar
  • 22 Riley BD, Culver JO, Skrzynia C , et al. Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors. J Genet Couns 2012; 21 (2) 151-161
    CrossrefPubMedSearch in Google Scholar
  • 23 Robson ME, Storm CD, Weitzel J, Wollins DS, Offit K ; American Society of Clinical Oncology. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol 2010; 28 (5) 893-901
    CrossrefPubMedSearch in Google Scholar
  • 24 Church J. Familial adenomatous polyposis. Surg Oncol Clin N Am 2009; 18 (4) 585-598
    CrossrefPubMedSearch in Google Scholar
  • 25 Kalady MF. Surgical management of hereditary nonpolyposis colorectal cancer. Adv Surg 2011; 45: 265-274
    CrossrefPubMedSearch in Google Scholar
  • 26 Kalady MF. Sessile serrated polyps: an important route to colorectal cancer. J Natl Compr Canc Netw 2013; 11 (12) 1585-1594
    PubMedSearch in Google Scholar
  • 27 Kalady MF, Church JM. Prophylactic colectomy: rationale, indications, and approach. J Surg Oncol 2015; 111 (1) 112-117
    CrossrefPubMedSearch in Google Scholar
  • 28 Bisgaard ML, Fenger K, Bülow S, Niebuhr E, Mohr J. Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat 1994; 3 (2) 121-125
    CrossrefPubMedSearch in Google Scholar
  • 29 National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Genetic/Familial High-Risk Assessment. Colorectal Cancer Version 1; 2015
    PubMed
  • 30 Grover S, Kastrinos F, Steyerberg EW , et al. Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas. JAMA 2012; 308 (5) 485-492
    PubMedSearch in Google Scholar
  • 31 Tenesa A, Campbell H, Barnetson R, Porteous M, Dunlop M, Farrington SM. Association of MUTYH and colorectal cancer. Br J Cancer 2006; 95 (2) 239-242
    CrossrefPubMedSearch in Google Scholar
  • 32 Gismondi V, Meta M, Bonelli L , et al. Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas. Int J Cancer 2004; 109 (5) 680-684
    CrossrefPubMedSearch in Google Scholar
  • 33 Sieber OM, Lipton L, Crabtree M , et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 2003; 348 (9) 791-799
    CrossrefPubMedSearch in Google Scholar
  • 34 Croitoru ME, Cleary SP, Berk T , et al. Germline MYH mutations in a clinic-based series of Canadian multiple colorectal adenoma patients. J Surg Oncol 2007; 95 (6) 499-506
    CrossrefPubMedSearch in Google Scholar
  • 35 Nielsen M, Franken PF, Reinards TH , et al. Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP). J Med Genet 2005; 42 (9) e54
    CrossrefPubMedSearch in Google Scholar
  • 36 Sampson JR, Dolwani S, Jones S , et al. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet 2003; 362 (9377) 39-41
    CrossrefPubMedSearch in Google Scholar
  • 37 Cleary SP, Cotterchio M, Jenkins MA , et al. Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. Gastroenterology 2009; 136 (4) 1251-1260
    CrossrefPubMedSearch in Google Scholar
  • 38 Aretz S, Stienen D, Uhlhaas S , et al. High proportion of large genomic deletions and a genotype phenotype update in 80 unrelated families with juvenile polyposis syndrome. J Med Genet 2007; 44 (11) 702-709
    CrossrefPubMedSearch in Google Scholar
  • 39 Howe JR, Sayed MG, Ahmed AF , et al. The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations. J Med Genet 2004; 41 (7) 484-491
    CrossrefPubMedSearch in Google Scholar
  • 40 van Hattem WA, Brosens LA, de Leng WW , et al. Large genomic deletions of SMAD4, BMPR1A and PTEN in juvenile polyposis. Gut 2008; 57 (5) 623-627
    CrossrefPubMedSearch in Google Scholar
  • 41 Friedl W, Uhlhaas S, Schulmann K , et al. Juvenile polyposis: massive gastric polyposis is more common in MADH4 mutation carriers than in BMPR1A mutation carriers. Hum Genet 2002; 111 (1) 108-111
    CrossrefPubMedSearch in Google Scholar
  • 42 Gallione CJ, Repetto GM, Legius E , et al. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 2004; 363 (9412) 852-859
    CrossrefPubMedSearch in Google Scholar
  • 43 O'Malley M, LaGuardia L, Kalady MF , et al. The prevalence of hereditary hemorrhagic telangiectasia in juvenile polyposis syndrome. Dis Colon Rectum 2012; 55 (8) 886-892
    CrossrefPubMedSearch in Google Scholar
  • 44 Amos CI, Keitheri-Cheteri MB, Sabripour M , et al. Genotype-phenotype correlations in Peutz-Jeghers syndrome. J Med Genet 2004; 41 (5) 327-333
    CrossrefPubMedSearch in Google Scholar
  • 45 Aretz S, Stienen D, Uhlhaas S , et al. High proportion of large genomic STK11 deletions in Peutz-Jeghers syndrome. Hum Mutat 2005; 26 (6) 513-519
    CrossrefPubMedSearch in Google Scholar
  • 46 Volikos E, Robinson J, Aittomäki K , et al. LKB1 exonic and whole gene deletions are a common cause of Peutz-Jeghers syndrome. J Med Genet 2006; 43 (5) e18
    PubMedSearch in Google Scholar
  • 47 Mester J, Eng C. Estimate of de novo mutation frequency in probands with PTEN hamartoma tumor syndrome. Genet Med 2012; 14 (9) 819-822
    CrossrefPubMedSearch in Google Scholar
  • 48 Pilarski R, Stephens JA, Noss R, Fisher JL, Prior TW. Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome clinical features. J Med Genet 2011; 48 (8) 505-512
    CrossrefPubMedSearch in Google Scholar
  • 49 Tan MH, Mester J, Peterson C , et al. A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands. Am J Hum Genet 2011; 88 (1) 42-56
    CrossrefPubMedSearch in Google Scholar
  • 50 Snover DC, Ahnen DJ, Burt RW, Odze R. Serrated polyps of the colon and rectum and serrated polyposis. In: Bosman FT, Carneiro F, Hruban RH, Theise HD, , eds. WHO Classification of Tumours of the Digestive System. Lyon, France: IARC; 2010: 160-165
    Search in Google Scholar
  • 51 Niessen RC, Hofstra RM, Westers H , et al. Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome. Genes Chromosomes Cancer 2009; 48 (8) 737-744
    CrossrefPubMedSearch in Google Scholar
  • 52 Ward RL, Dobbins T, Lindor NM, Rapkins RW, Hitchins MP. Identification of constitutional MLH1 epimutations and promoter variants in colorectal cancer patients from the Colon Cancer Family Registry. Genet Med 2013; 15 (1) 25-35
    CrossrefPubMedSearch in Google Scholar
  • 53 Lindor NM, Petersen GM, Hadley DW , et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 2006; 296 (12) 1507-1517
    CrossrefPubMedSearch in Google Scholar
  • 54 Hu H, Wrogemann K, Kalscheuer V , et al. Mutation screening in 86 known X-linked mental retardation genes by droplet-based multiplex PCR and massive parallel sequencing. Hugo J 2009; 3 (1–4) 41-49
    CrossrefPubMedSearch in Google Scholar
  • 55 Meder B, Haas J, Keller A , et al. Targeted next-generation sequencing for the molecular genetic diagnostics of cardiomyopathies. Circ Cardiovasc Genet 2011; 4 (2) 110-122
    CrossrefPubMedSearch in Google Scholar
  • 56 Morgan JE, Carr IM, Sheridan E , et al. Genetic diagnosis of familial breast cancer using clonal sequencing. Hum Mutat 2010; 31 (4) 484-491
    CrossrefPubMedSearch in Google Scholar
  • 57 Pritchard CC, Smith C, Salipante SJ , et al. ColoSeq provides comprehensive Lynch and polyposis syndrome mutational analysis using massively parallel sequencing. J Mol Diagn 2012; 14 (4) 357-366
    CrossrefPubMedSearch in Google Scholar
  • 58 Walsh T, Lee MK, Casadei S , et al. Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing. Proc Natl Acad Sci U S A 2010; 107 (28) 12629-12633
    CrossrefPubMedSearch in Google Scholar
  • 59 Mauer CB, Pirzadeh-Miller SM, Robinson LD, Euhus DM. The integration of next-generation sequencing panels in the clinical cancer genetics practice: an institutional experience. Genet Med 201; 16 (5) 407-412
    PubMed
  • 60 Yurgelun MB, Allen B, Kaldate R , et al. Germline mutations identified by a 25 gene panel in patients undergoing Lynch syndrome testing. Presented at the 17th Annual Meeting of the Collaborative Group of the Americas on Inherited Colorectal Cancer. Anaheim, CA; 2013
    PubMed
  • 61 Palles C, Cazier JB, Howarth KM , et al; CORGI Consortium; WGS500 Consortium. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat Genet 2013; 45 (2) 136-144
    PubMedSearch in Google Scholar
  • 62 Jaeger E, Leedham S, Lewis A , et al. Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1. Nat Genet 2012; 44 (6) 699-703
    CrossrefPubMedSearch in Google Scholar
  • 63 Bakry D, Aronson M, Durno C , et al. Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium. Eur J Cancer 2014; 50 (5) 987-996
    CrossrefPubMedSearch in Google Scholar
  • 64 Wong P, Verselis SJ, Garber JE , et al. Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome. Gastroenterology 2006; 130 (1) 73-79
    CrossrefPubMedSearch in Google Scholar
  • 65 Fitzgerald RC, Hardwick R, Huntsman D , et al; International Gastric Cancer Linkage Consortium. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet 2010; 47 (7) 436-444
    CrossrefPubMedSearch in Google Scholar